Side-by-side comparison of AI visibility scores, market position, and capabilities
St. Louis MO regulated utility (NYSE: AEE) ~$8.2B revenue; 2.4M electric + 900K gas customers in MO/IL, 250MW solar project near Callaway Nuclear (2028), formula rate in Illinois competing with Evergy.
Ameren Corporation is a St. Louis, Missouri-based regulated electric and natural gas utility holding company — publicly traded on the New York Stock Exchange (NYSE: AEE) as an S&P 500 Utilities component — serving approximately 2.4 million electric customers and 900,000 natural gas customers in Missouri and Illinois through two primary regulated subsidiaries: AmerenMissouri (electric and gas in Missouri, including the Callaway Nuclear Power Station — Missouri's only commercial nuclear plant) and AmerenIllinois (electric and gas distribution across central and southern Illinois), through approximately 9,000 employees. In fiscal year 2024, Ameren reported revenue of approximately $8.2 billion, with continued capital investment in transmission upgrades, distribution modernization, and renewable energy additions. Ameren Missouri's clean energy transition includes the announced Reform Renewable Energy Center — a 250-megawatt solar facility near the Callaway Nuclear site, with construction beginning in 2026 and expected to power 44,000 homes by 2028, creating 300 construction jobs. CEO Martin Lyons, who succeeded Warner Baxter in 2022, has maintained Ameren's steady capital investment trajectory targeting 6-8% annual EPS growth through infrastructure modernization and renewable energy additions in both states. The company's transmission infrastructure — spanning MISO (Midcontinent Independent System Operator) in Missouri and PJM Interconnection in Illinois — positions Ameren to benefit from grid investment programs enabling renewable energy integration across the Midwest.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.